Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

Eczema is a condition that causes patches of skin to become dry, inflamed, and irritated,” explains Joel Schlessinger, MD, a board-certified dermatologist in Omaha, NE and RealSelf contributor. “It’s ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

One study found that pain was self-reported as a symptom in over 4 in 10 people with plaque psoriasis. For some others, the same immune system that causes plaque on your skin could instead inflame ...

Red, scaly skin patches are the main symptom of psoriasis. There’s no cure for ... So start your day by using a soft washcloth and a mild cleanser to gently rub away flaking skin.

Sotyktu (deucravacitinib) is a brand-name oral tablet that’s prescribed for plaque psoriasis in certain adults ... who took Sotyktu in clinical trials: Mild side effects can occur with Sotyktu ...

Mild tricuspid valve regurgitation isn’t usually a cause for alarm, especially if you don’t have anatomical issues. About 80% of the population has mild asymptomatic tricuspid regurgitation ...

It's important to note that the world of hybrids encompasses various types, including full hybrids and mild hybrids. Each offers a unique blend of fuel efficiency and performance. In order to give ...

White matter and other changes around the toenails and fingernails can occur with psoriasis or nail fungus. However, fungal infections are contagious, and psoriasis is not. The causes and ...

They are almost always mild and resolve quickly ... quickly and does not recur with subsequent dosing. Each systemic psoriasis medication has its own adverse event profile. For the entire class ...

As a non-opioid drug, Journavx can assist patients effectively and without showing signs of being addictive. The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a ...